83 Results

People

  1. Kris
    Kris
  2. Chou
    Chou
  3. Fair
    Fair
  4. Motzer
    Motzer
  5. O'Reilly
    O'Reilly
  6. Rabbani
    Rabbani
  7. Bastar
    Bastar
  8. Fong
    Fong
  9. Hellmann
    Hellmann
  10. Morris
    Morris

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)
  7. Breast Medicine Service (9)
  8. Center for Pancreatic Cancer Research (9)
  9. GSK Faculty (9)
  10. Epidemiology and Biostatistics (8)
  1. "combination"
Formats
  1. Journal Article (69)
  2. Review (7)
  3. Conference Paper (3)
  4. Book Section (2)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)

More Groups

People
  1. Ting-Chao Chou (6)
  2. Mark Kris (5)
  3. Eileen O'Reilly (4)
  4. Farhang Rabbani (4)
  5. Robert Motzer (4)
  6. William Fair (4)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. Annals of Oncology (3)
  4. Clinical Cancer Research (3)
  5. Molecular Urology (3)
  6. Seminars in Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (8)
  3. Oxford University Press (6)
  4. American Association for Cancer Research (5)
  5. Biomed Central Ltd (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
    Journal Article

    Robles-Oteíza, C.; Hastings, K.; Choi, J.; Sirois, I.; Ravi, A.; Expósito, F.; de Miguel, F.; Knight, J. R.; López-Giráldez, F.; Choi, H.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: Final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial
    Journal Article

    Coleman, R. L.; Lorusso, D.; Oaknin, A.; Cecere, S. C.; Denys, H.; Colombo, N.; van Gorp, T.; Konner, J. A.; Marin, M. R.; Harter, P.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Complete remission of widely metastatic human epidermal growth factor receptor 2-amplified pancreatic adenocarcinoma after precision immune and targeted therapy with description of sequencing and organoid correlates
    Journal Article

    King, D. A.; Smith, A. R.; Pineda, G.; Nakano, M.; Michelini, F.; Goedegebuure, S. P.; Thyparambil, S.; Liao, W. L.; McCormick, A.; Ju, J. H.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)
    Journal Article

    Morris, M. J.; Heller, G.; Hillman, D. W.; Bobek, O.; Ryan, C.; Antonarakis, E. S.; Bryce, A. H.; Hahn, O.; Beltran, H.; Armstrong, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Anti-PD-1 monoclonal antibodies (mAbs) are superior to Anti-PD-L1 mAbs when combined with chemotherapy in first-line treatment for metastatic non-small cell lung cancer (mNSCLC): A network meta-analysis
    Journal Article

    Wei, J. Q.; Yuile, A.; Itchins, M.; Kong, B. Y.; Li, B. T.; Pavlakis, N.; Chan, D. L.; Clarke, S. J.
    Biomedicines (2023)

    Fulltext@MSK | Save
  • Is there a pathway for phosphatidylinositol 3-kinase delta inhibitors to be approved therapeutics for B-cell lymphoma therapy
    Editorial

    Luttwak, E.; Smith, M. R.; Zelenetz, A. D.
    Expert Opinion on Pharmacotherapy (2023)

    Fulltext@MSK | Save
  • Induction and preliminary characterization of neoplastic pulmonary nodules in a transgenic pig model
    Journal Article

    Ghosn, M.; Elsakka, A. S.; Petre, E. N.; Cheleuitte-Nieves, C.; Tammela, T.; Monette, S.; Ziv, E.; Schachtschneider, K. M.; Srimathveeravalli, G.; Yarmohammadi, H.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Irinotecan dose schedule for the treatment of Ewing sarcoma
    Review

    Slotkin, E. K.; Meyers, P. A.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation
    Journal Article

    Mathur, D.; Taylor, B. P.; Chatila, W. K.; Scher, H. I.; Schultz, N.; Razavi, P.; Xavier, J. B.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save